By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies and Sage Science today announced a co-marketing deal covering each other's technologies for next-generation sequencing applications.

The deal covers Agilent's 2100 Bioanalyzer for detecting and quantifying nucleic acids and Sage's Pippin Prep DNA size selection system. In addition to co-promoting the platforms, the partners will develop application studies that leverage the combined capabilities of the two systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.